ConductScience.org, home

Paper30419600

The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role.

Madunić J. Thromb Haemost, 2018. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role. Papers, record 30419600. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30419600

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive Role.
PubMed
Journal
Thromb Haemost
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2019-01-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Madunić JJosip

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Extracellular MatrixMajor topic
FibrinolysinMajor topic
NeoplasmsMajor topic
Urokinase-Type Plasminogen ActivatorMajor topic
Carcinogenesis
Humans
Neoplasm Metastasis
Predictive Value of Tests
Prognosis
Proteolysis
Ubiquitination

Source PubMed

Download CSV of topics

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
42379802Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells In Vitro.In Vivo2026https://conductscience.org/library/papers/42379802PubMed
42234219Modeling the role of urokinase-type plasminogen activator, uPA, and circulating cancer-associated fibroblasts (cCAFs) in breast cancer cell extravasation.Clin Exp Metastasis2026https://conductscience.org/library/papers/42234219PubMed
41901243A Mechanistic Digital Twin of uPAR-Driven Prostate Cancer Invasion Integrating ODE Signalling and Agent-Based Modelling.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901243PubMed
41858315A contemporary review of plasminogen activator inhibitor 1 in cardiovascular disease and broader disease state implications.Blood Vessel Thromb Hemost2026https://conductscience.org/library/papers/41858315PubMed
41559139From in-silico QSAR modeling to in-vitro MTT assay: experimental validation of novel uPAR leads for triple-negative breast cancer (TNBC) and skin cancer.Sci Rep2026https://conductscience.org/library/papers/41559139PubMed
39744227Optical molecular imaging in oral- and oropharyngeal squamous cell carcinoma using a novel uPAR-targeting near-infrared imaging agent FG001 (ICG-Glu-Glu-AE105): An explorative phase II clinical trial.Theranostics2025https://conductscience.org/library/papers/39744227PubMed
39678603PRKD3 promotes proliferation of liver cancer cells: a downstream proteomics profiling study.Am J Transl Res2024https://conductscience.org/library/papers/39678603PubMed
38715331Endothelial-specific Enhancer as a Cis Element of PLAUR Regulation by TNF-alpha, IL-1beta, and VEGF.Curr Pharm Des2024https://conductscience.org/library/papers/38715331PubMed
38275392Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma.Biomedicines2023https://conductscience.org/library/papers/38275392PubMed
38103082miR-181a plays the tumor-suppressor role in chronic myeloid leukemia CD34 + cells partially via SERPINE1.Cell Mol Life Sci2023https://conductscience.org/library/papers/38103082PubMed
36942151Fibrinolysis: an illustrated review.Res Pract Thromb Haemost2023https://conductscience.org/library/papers/36942151PubMed
36598826The roles of proteases in prostate cancer.IUBMB Life2023https://conductscience.org/library/papers/36598826PubMed
36415513Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation.J Med Life2022https://conductscience.org/library/papers/36415513PubMed
36124441Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study.Biomol Biomed2023https://conductscience.org/library/papers/36124441PubMed
35775375Expression patterns of uPAR, TF and EGFR and their potential as targets for molecular imaging in oropharyngeal squamous cell carcinoma.Oncol Rep2022https://conductscience.org/library/papers/35775375PubMed
35480116Cancer Progression Gene Expression Profiling Identifies the Urokinase Plasminogen Activator Receptor as a Biomarker of Metastasis in Cutaneous Squamous Cell Carcinoma.Front Oncol2022https://conductscience.org/library/papers/35480116PubMed
35303878Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.J Transl Med2022https://conductscience.org/library/papers/35303878PubMed
35087738Prognostic Significance and Gene Co-Expression Network of PLAU and PLAUR in Gliomas.Front Oncol2021https://conductscience.org/library/papers/35087738PubMed
34771541The Urokinase Receptor (uPAR) as a "Trojan Horse" in Targeted Cancer Therapy: Challenges and Opportunities.Cancers (Basel)2021https://conductscience.org/library/papers/34771541PubMed
34732728Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.Nat Commun2021https://conductscience.org/library/papers/34732728PubMed

See all 33 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PLAU5328PubTator's text mininghttps://conductscience.org/library/genes/5328NCBI Gene
PLAUR5329PubTator's text mininghttps://conductscience.org/library/genes/5329NCBI Gene
PLG5340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30419600

GET https://conductscience.org/api/papers/v1/30419600/cited_by?page=2